Advancing preclinical cancer models to assess clinically relevant outcomes

Anna Golebiewska*, Ryan C. Fields

*Corresponding author for this work

Research output: Contribution to journalEditorial

1 Citation (Scopus)


Cancer models are indispensable research tools for elucidating the mechanisms involved in tumor onset, progression and treatment resistance. They are key in evaluating therapeutics prior clinical trials. In this editorial, we invite contributions for a BMC Cancer’s Collection of articles addressing ‘Advances in pre-clinical cancer models’ towards relivable outcomes at the preclinical stage.

Original languageEnglish
Article number230
JournalBMC Cancer
Issue number1
Publication statusPublished - 10 Mar 2023


Dive into the research topics of 'Advancing preclinical cancer models to assess clinically relevant outcomes'. Together they form a unique fingerprint.

Cite this